Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection?
Olivier MarionSébastien LhommeFlorence AbravanelJacques IzopetNassim KamarPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)